Table 1_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Image 1_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.jpg by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Image 3_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.jpg by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Table 2_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Image 2_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.jpg by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Table 3_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Table 4_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Table 9_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Table 7_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Table 14_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Table 6_Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032.xlsx by Hongxia Yuan (9992177)

“…Background<p>Measles remains a major disease burden on children and adolescents in BRICS-plus countries (Brazil, Russia, India, China, South Africa, and five others) despite vaccine efficacy. …”

Data Sheet 1_Global assessment of terrestrial precipitation and evapotranspiration in CMIP6 simulations using observation-based estimates.docx by Shanshan Sun (275585)

“…We assess these variables using observation-based estimates from three Pr datasets (CRU4.0, GPCP v2.3, ERA5) and four land surface flux datasets (GLEAM v3.3a, GLDAS v2.0, ERA5-Land, MERRA-Land). …”

Non-indicated use of prophylactic antibiotics in gynaecological surgery at an academic tertiary medical centre by Kevin M. Kremer (4824024)

<i>Tmprss2^−/−</i> mutant mice do not exhibit drop in blood oxygen saturation. by Bastian Hatesuer (493136)

“…<i>Tmprss2^−/−</i> mice showed only a very mild drop in oxygen saturation whereas wild type mice exhibited a significant decrease that peaked at day 8 p.i.…”

The Expression of NFκB and Downstream Angiogenic Proteins in rho/VEGF Mouse Model. by Michael DeNiro (297385)

“…YC-1-treated retinas exhibited a significant decrease in the protein expression levels as compared with DMSO-treated retinas. …”

The Expression of NFκB and Downstream Angiogenic Proteins in rho/VEGF Mouse Model. by Michael DeNiro (297385)

“…YC-1-treated retinas exhibited a significant decrease in the protein expression levels as compared with DMSO-treated retinas. …”

Recognition of native trimers. by Ilja Bontjer (426978)

“…<p>The binding of sera from ΔV1V2-immunized rabbits to native JR-FL Env trimers was examined. nAbs b12 and 2F5 and nonneutralizing antibody 15e served as controls. …”

Susceptibility of PG Isolated from WT and Various Mutants to Hydrolysis by Lysozyme by Silvia Herbert (33126)

“…Lysis of PG was measured as a decrease in OD_660nm and calculated in percent. …”

Examination of early postnatal stages in OC2-KO retinas. by Jillian J. Goetz (644028)

“…Age-matched animals were processed for either retinal sections (P5) or flatmounts (P10) and stained with an anti-Rhodopsin antibody (A,A’), an anti-Chx10 antibody (B,B’), or an anti-Calbindin 28k antibody (C,C’,D,D’). …”

Conditional expression of <i>RockDN</i> in NCC. by Helen M. Phillips (163641)

“…There is a statistically significant (P<0.05 *), 13 fold decrease, in the expression of the <i>CAT</i> box in the mutant sample, as calculated using the one-way Anova test.…”